-
公开(公告)号:EP2498607A4
公开(公告)日:2013-06-19
申请号:EP10830814
申请日:2010-11-12
申请人: GENOSCO , OSCOTEC INC
发明人: LEE JAEKYOO , SONG HO-JUHN , KOH JONG SUNG , LEE HEE KYU , KIM YOUNGSAM , KIM HONG WOO , CHANG SUNHWA , LIM SUN-HEE , CHOI JANG-SIK , KIM JUNG-HO , KIM SE-WON
IPC分类号: A01N43/54 , A61K31/505 , C07D403/04 , C07D403/14 , C07D405/14 , C07D417/14
CPC分类号: A61K31/505 , C07D403/04 , C07D403/14 , C07D405/14 , C07D417/14 , C07D487/08
-
公开(公告)号:EP2493313A4
公开(公告)日:2013-05-15
申请号:EP10827573
申请日:2010-10-29
申请人: GENOSCO , OSCOTEC INC
发明人: KIM HONG WOO , KOH JONG SUNG , LEE JAEKYOO , SONG HO-JUHN , KIM YOUNGSAM , LEE HEE KYU , CHOI JANG-SIK , LIM SUN-HEE , CHANG SUNHWA
IPC分类号: A61K31/519 , A61P25/28 , A61P29/00 , A61P35/00 , C07D471/04
CPC分类号: A61K31/519 , C07D471/04
摘要: The present invention provides a new group of protein kinase inhibitors, pyrido[4,3,-d]pyrimidin-5-one derivatives, and pharmaceutically acceptable salts thereof that are useful for intreating cell proliferative disease and disorder such as cancer, autoimmune diseases, infection, cardiovascular disease and neurodegenerative disease and disorder. The present invention provides methods for synthesizing and administering the protein kinase inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the protein kinase inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefor. The invention also provides useful intermediates generated during the syntheses of the pyrido[4,3,-d]pyrimidin-5-one derivatives.
摘要翻译: 本发明提供了一组新的蛋白激酶抑制剂,吡啶并[4,3,-d]嘧啶-5-酮衍生物及其药学上可接受的盐,其可用于促进细胞增殖性疾病和病症如癌症,自身免疫性疾病, 感染,心血管疾病和神经变性疾病和障碍。 本发明提供了合成和施用蛋白激酶抑制剂化合物的方法。 本发明还提供了包含至少一种蛋白激酶抑制剂化合物以及药学上可接受的载体,稀释剂或赋形剂的药物制剂。 本发明还提供了在吡啶并[4,3, - d]嘧啶-5-酮衍生物的合成过程中产生的有用的中间体。
-